CLIFTON R. LADUANE (CFO, Secretary & Treasurer) purchased 14.1% of their position (1K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $6.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/3/2022ACC: 0001437749-22-023512
Officer· CFO, Secretary & Treasurer
Since Oct 2018
+1K
Net shares
Net buyer
$6.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+600.00
Price / share
$5.98
Trade value
$3.59K
% of position
8.4%
9/30/2022
7.11K→7.71K
Common Stock
Direct
Shares
+400.00
Price / share
$5.98
Trade value
$2.39K
% of position
5.2%
9/30/2022
7.71K→8.11K
Total
Net shares
+1K
Net value
$5.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2022 | P · Purchase | +600.00 | $5.98 | $3.59K | 8.4% | 7.11K | 7.71K |
| Common Stock Direct | 9/30/2022 | P · Purchase | +400.00 | $5.98 | $2.39K | 5.2% | 7.71K | 8.11K |
| Total | +1K | $5.98K | ||||||
Derivative Transactions0
No derivative transactions reported